Lupin to acquire Australia-based Southern Cross Pharma

Generic Health, the Australia based wholly-owned subsidiary of Lupin, has entered into a definitive agreement under which Lupin will acquire 100 per cent of the shares of Southern Cross Pharma Pty Ltd (SCP), Lupin said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3lbIV7F
via IFTTT